our EXPERTISE IN RARE DISEASES
Making a major impact on global healthcare
We specialize in rare diseases continuously expanding our portfolio across therapeutic areas, and delivering excellence in orphan drug pathways with a proven track record in launching orphan and ultra orphan products
Why do we care about rare diseases?
CAGR 12%
$ 340B
Estimated
market
size for
2028
market
size for
2028
$ 194B
2023
$194 B
Market size
in 2023
in 2023
$340 B
Estimated market
size for 2028
size for 2028
7.000
Rare diseases identified in the world
10%
Global population affected by rare diseases
700
Rare diseases have FDA-approved treatment
450M +
People worldwide living without a treatment
At Biomedica, we uphold the principle that every individual, regardless of their origin or location, deserves equitable access to healthcare. Our dedication lies in advancing health equity for patients with rare diseases.
We specialize in six therapeutic areas
Rare diseases
Oncology
Hematology
Hepatology
Neurology
Ophthalmology
Looking for a strategic guidance?
Reach out to our team for market assessment specific to your product and understand the financial impact you can achieve by partnering with us.